TickerFactsScreenerDevelopers

Aptose Biosciences Inc. (APTOF) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $10.63M2018: $15.30M2019: $79.84M2020: $117.39M2021: $39.11M2022: $36.97M2023: $9.25M2024: $6.15M2025: $935.0K$935.0K
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$935.0K-84.8%
2024$6.15M-33.5%
2023$9.25M-75.0%
2022$36.97M-5.5%
2021$39.11M-66.7%
2020$117.39M+47.0%
2019$79.84M+421.9%
2018$15.30M+43.9%
2017$10.63M—